Basic Information

Common name
B-Luc-EGFP MV-4-11
Catalog number
Biphenotypic B myelomonocytic leukemia
Tissue types
Peripheral blood
Peripheral blood
B-Luc-EGFP MV-4-11 cell line can be used to evaluate anti-cancer drugs in biphenotypic B myelomonocytic leukemia in vivo.

Targeting strategy

Gene targeting strategy for B-Luc-EGFP MV-4-11 cells. The exogenous promoter and luciferase-EGFP were inserted into the targeting vector used in the lentivirus system.

In vitro luciferase activity of B-Luc-EGFP MV-4-11 cells

Luminescence signal intensity of B-Luc-EGFP MV-4-11 cells. Luminescence intensity was measured using the Bright-GloTM luciferase Assay (Promega, Cat E2610). B-Luc-EGFP MV-4-11 cells have a strong luminescence signal. EGFP was detected in B-Luc-EGFP MV-4-11 cells. The 1-D02 clone of B-Luc-EGFP MV-4-11 cells can be used in vivo experiments.

Quantitative imaging data & body weight changes

Tumor growth and in vivo imaging of B-Luc-EGFP MV-4-11 cells. B-Luc-EGFP MV-4-11 cells (1×106) were injected into the tail vein of wild-type B-NDG mice. Signal intensity and body weight were measured twice a week. (A) Imaging was performed twice a week. (B) Body weight (Mean ± SEM). B-Luc-EGFP MV-4-11 cells can be used for in vivo efficacy evaluation.

Imaging analysis in vivo